BEIJING BEILU PHARMACEUTICAL

beijing-beilu-pharmaceutical-logo

Beijing Beilu Pharmaceutical mainly engaged in the research and development, production, and sales of pharmaceutical products. It is a national high-tech enterprise, one of the first batch of listed enterprises in Growth Enterprises Market (stock code 300016), and a leading contrast agent enterprise. Beilu is the first company to develop and launch the contrast agent products in China, filling the gap in the domestic market, and forming a unique core competitive advantage in this field is the market leader in the domestic contrast agent industry. In addition, the company has also strengthened R&D in the field of psychoneurosis and endocrinology drugs, and strive to achieve variety diversification.

#SimilarOrganizations #Financial #More

BEIJING BEILU PHARMACEUTICAL

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Euro PHP PHP 7 Pound Sterling Ubuntu Japanese Yen


Similar Organizations

apeloa-pharmaceutical-logo

Apeloa Pharmaceutical

Apeloa Pharmaceutical engaged in the research, development, production and sale of medicines.

biokin-pharmaceutical-logo

Biokin Pharmaceutical

Biokin Pharmaceutical engages in the R&D, production and sales of pharmaceutical products.

hunan-nucien-pharmaceutical-logo

Hunan Nucien Pharmaceutical

Hunan Nucien engages in the research and development, production, and sale of pharmaceutical product

Stock Details


Company's stock symbol is SZSE:300016

Investments List

Date Company Article Money raised
2016-06-01 Geneseeq Beijing Beilu Pharmaceutical investment in Series B - Geneseeq 60 M CNY
2014-08-01 Geneseeq Beijing Beilu Pharmaceutical investment in Series A - Geneseeq 30 M CNY

More informations about "Beijing Beilu Pharmaceutical" on Search Engine